Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bachelot

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Journal of Biological Chemistry|December 15, 1991
Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphateC Sultan, M Plantavid, C Bachelot, et al.
Medical and Pediatric Oncology|January 1, 1994
Leukemic ophthalmopathy: a report of 21 pediatric casesM Lo Curto, P D'Angelo, F Lumia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric OncologyM F Tournade, J Lemerle, M Brunat-Mentigny, et al.
British Journal of Pharmacology|September 15, 2011
Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonistM Dumas, F Nadal-Wollbold, P Gaussem, et al.
Bulletin Du Cancer|January 1, 1988
[The reproduction in France of Rosen's protocol for osteosarcomas]M Brunat-Mentigny, M C Demaille, E Quitana, et al.
The Biochemical Journal|November 22, 2001
Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domainD Borgel, P Gaussem, C Garbay, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Platelet dysfunction associated with the novel Trp29Cys thromboxane A₂ receptor variantA D Mumford, S Nisar, L Darnige, et al.
Immunology Today|November 1, 1996
CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndromeL D Notarangelo, M C Peitsch, T G Abrahamsen, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Journal of Biological Chemistry|December 15, 1991
Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphateC Sultan, M Plantavid, C Bachelot, et al.
Medical and Pediatric Oncology|January 1, 1994
Leukemic ophthalmopathy: a report of 21 pediatric casesM Lo Curto, P D'Angelo, F Lumia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric OncologyM F Tournade, J Lemerle, M Brunat-Mentigny, et al.
British Journal of Pharmacology|September 15, 2011
Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonistM Dumas, F Nadal-Wollbold, P Gaussem, et al.
Bulletin Du Cancer|January 1, 1988
[The reproduction in France of Rosen's protocol for osteosarcomas]M Brunat-Mentigny, M C Demaille, E Quitana, et al.
The Biochemical Journal|November 22, 2001
Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domainD Borgel, P Gaussem, C Garbay, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Platelet dysfunction associated with the novel Trp29Cys thromboxane A₂ receptor variantA D Mumford, S Nisar, L Darnige, et al.
Immunology Today|November 1, 1996
CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndromeL D Notarangelo, M C Peitsch, T G Abrahamsen, et al.
Pageof 6